I have the PICOT question formed and articles pulled PICOT Question: In adults w
I have the PICOT question formed and articles pulled PICOT Question: In adults with existing COPD(P), does Varenicline (I) in comparison to nicotine replacement therapy (NRT) (C) have a higher success rate in COPD patients attempts to quit smoking (O) in a 12-month period(T)? References: Baker, T. B., Piper, M. E., Smith, S. S., Bolt, D. M., Stein, J. H., & Fiore, M. C. (2021). Effects of combined varenicline with nicotine patch and of extended treatment duration on smoking cessation. JAMA, 326(15), 1485. Retrieved June 19, 2022, from https://doi.org/10.1001/jama.2021.15333 Baker, T. B., Piper, M. E., Stein, J. H., Smith, S. S., Bolt, D. M., Fraser, D. L., & Fiore, M. C. (2016). Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks. JAMA, 315(4), 371. Retrieved June 19, 2022, from https://doi.org/10.1001/jama.2015.19284 Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013). Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database of Systematic Reviews, 2015(7). Retrieved June 19, 2022, from https://doi.org/10.1002/14651858.cd009329.pub2 Ellerbeck, E. F., Nollen, N., Hutcheson, T. D., Phadnis, M., Fitzgerald, S. A., Vacek, J., Sharpe, M. R., Salzman, G. A., & Richter, K. P. (2018). Effect of long-term nicotine replacement therapy vs standard smoking cessation for smokers with chronic lung disease. JAMA Network Open, 1(5), e181843. Retrieved June 19, 2022, from https://doi.org/10.1001/jamanetworkopen.2018.1843 García-Gómez, L., Hernández-Pérez, A., Noé-Díaz, V., Riesco-Miranda, J., & Jiménez-Ruiz, C. (2019). Smoking cessation treatments: Current psychological and pharmacological options. Revista de investigacin Clnica, 71(1). Retrieved June 19, 2022, from https://doi.org/10.24875/ric.18002629 Kim, N., McCarthy, D. E., Piper, M. E., & Baker, T. B. (2020). Comparative effects of varenicline or combination nicotine replacement therapy versus patch monotherapy on candidate mediators of early abstinence in a smoking cessation attempt. Addiction, 116(4), 926–935. Retrieved June 19, 2022, from https://doi.org/10.1111/add.15248 Le Mao, R., Tromeur, C., Paleiron, N., Sanchez, O., Gagnadoux, F., Jouneau, S., Magnan, A., Hayem-Vannimenus, C., Dansou, A., Proust, A., Dion, A., Larhantec, G., Brestec, A., Dewitte, J.-D., Roche, N., Leroyer, C., & Couturaud, F. (2019). Effect of early initiation of varenicline on smoking cessation in copd patients admitted for exacerbation: The save randomized clinical trial. COPD: Journal of Chronic Obstructive Pulmonary Disease, 17(1), 7–14. Retrieved June 19, 2022, from https://doi.org/10.1080/15412555.2019.1703928 Politis, A., Ioannidis, V., Gourgoulianis, K. I., Daniil, Z., & Hatzoglou, C. (2017). Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of copd, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial. Chronic Respiratory Disease, 15(2), 146–156. Retrieved June 19, 2022, from https://doi.org/10.1177/1479972317740128 Qin, R., Liu, Z., Zhou, X., Cheng, A., Cui, Z., Li, J., Wei, X., Xiao, D., & Wang, C. (2021). Adherence and efficacy of smoking cessation treatment among patients with copd in china. International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 1203–1214. Retrieved June 19, 2022, from https://doi.org/10.2147/copd.s301579 Sansores, R. H., Ramírez-Venegas, A., Arellano-Rocha, R., Noé-Díaz, V., García-Gómez, L., Pérez Bautista, O., & Velázquez Uncal, M. (2016). Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: A pilot study. Therapeutic Advances in Respiratory Disease, 10(5), 383–390. Retrieved June 19, 2022, from https://doi.org/10.1177/1753465816654823

Leave a Reply

Your email address will not be published. Required fields are marked *